Physician profile
Kevin Herman
NPI 1619107703
$153,940.00
in general payments reported to CMS, 2019-2025
41 companies · $19K in 2025
The $19K reported for 2025 was more than what 92% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,094 · 2020: $18K · 2021: $26K · 2022: $38K · 2023: $21K · 2024: $25K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $48K · Food and Beverage: $7,533 · Consulting Fee: $6,850 · Travel and Lodging: $1,570 · Honoraria: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $47,772.22 |
| Food and Beverage | $7,532.58 |
| Consulting Fee | $6,850.00 |
| Travel and Lodging | $1,569.63 |
| Honoraria | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $119,204.14 | 2019-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Cordis US Corp. | $10,119.70 | 2022-2023 | Brite Tip, Saber |
| Cardinal Health 200 LLC | $5,281.57 | 2019-2021 | |
| Cardiovascular Systems INC. | $3,900.57 | 2019-2023 | |
| Reflow Medical INC | $3,465.57 | 2023-2025 | |
| Endologix LLC | $2,254.42 | 2019-2025 | Endocross Device, Torus Stent Graft System |
| Abbott Laboratories | $1,851.90 | 2019-2025 | Esprit, Absolute Pro, Supera |
| Penumbra, INC. | $1,426.73 | 2022-2024 | Indigo System |
| Bard Peripheral Vascular, INC. | $1,335.41 | 2019-2024 | Pristine, Lutonix Drug Coated Balloon, Crosser Iq |
| Silk Road Medical, INC. | $1,027.86 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Philips North America LLC | $756.45 | 2019-2023 | (6554) Periph Vasc Undiv |
| Medtronic, INC. | $694.94 | 2021-2025 | Hawkone, Abre, Pacific Xtreme |
| Vasorum USA INC. | $419.08 | 2024 | Celt Acd |
| Inari Medical, INC. | $387.20 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $256.06 | 2023-2025 | Enroute Transcarotid Neuroprotection System, General - Vascular Intervention, Ranger |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $216.21 | 2023-2024 | |
| Neuros Medical, INC. | $178.83 | 2025 | Altius |
| Shockwave Medical, INC | $129.81 | 2024-2025 | Shockwave S4 |
| Mozarc Medical US LLC | $119.05 | 2024 | Argyle |
| Contego Medical, INC | $116.94 | 2024 | |
| Intact Vascular, INC. | $95.17 | 2019 | |
| Siemens Medical Solutions USA, INC. | $91.51 | 2019 | |
| Limflow INC. | $73.17 | 2023 | Limflow System |
| Inquis Medical, INC. | $66.96 | 2024 | |
| Veryan Medical Incorporated | $63.28 | 2020-2022 | |
| Trisalus Life Sciences, INC. | $61.25 | 2023-2024 | Trinav Infusion System |
| Medtronic USA, INC. | $53.77 | 2019 | |
| Janssen Pharmaceuticals, INC | $53.47 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $42.95 | 2019 | |
| Smith+Nephew, INC. | $33.24 | 2023-2024 | Collagenase Santyl |
| Terumo Medical Corporation | $29.29 | 2021 | |
| Baxter Healthcare | $27.18 | 2024 | Renal - Pd |
| Surmodics, INC. | $24.42 | 2024 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Imperative Care, INC | $21.46 | 2023 | Prodigy Catheter |
| Stryker Corporation | $18.83 | 2025 | Inthrill Thrombectomy Catheter |
| W. L. Gore & Associates, INC. | $18.81 | 2019 | |
| Cardiva Medical, INC. | $11.88 | 2021 | |
| Getinge USA Sales, LLC | $10.92 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$120,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.